Medication Guide App

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Pharma Industry News

Monthly News Roundup - March 2015

FDA Approves First Biosimilar Product Zarxio On Friday, March 6th the U.S. Food and Drug Administration (FDA) approved Sandoz’s Zarxio (filgrastim-sndz), the first U.S. approved biosimilar. Zarxio, the biosimilar for Amgen’s filgrastim (Neupogen), is a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer...

Posted today in Medical

Eat Right to Protect Your Sight

A number of nutrients can help keep your eyes healthy, and some may even improve your eyesight, an eye doctor says. It's particularly important to eat a variety of fresh fruits and vegetables, said Dr. James McDonnell, a pediatric ophthalmologist at Loyola University Health System in Maywood, Ill. "Make a colorful plate, especially with greens, blues...

Posted today in Medical

Benefits of Iron Supplements Unclear for Pregnant Women, Young Children

Taking iron supplements during pregnancy doesn't appear to significantly change any health outcomes for mom or baby, a new review shows. A second review -- this one on infants and toddlers -- found no evidence that iron supplements improved growth or development. Both conclusions come from a U.S. Preventive Services Task Force (USPSTF) review of the...

Posted yesterday in New Drug Approvals

FDA Approves New Crushing Option for the Administration of Brilinta

AstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow Brilinta 90 mg tablets whole. Unlike other P2Y12 inhibitors, Brilinta has FDA approval to be crushed and administered in water by swallowing or via nasogastric...

Posted yesterday in New Drug Approvals

FDA Approves Jadenu (deferasirox) Tablets for Chronic Iron Overload

EAST HANOVER, N.J., March 30, 2015 Novartis announced today that the US Food and Drug Administration (FDA) has approved Jadenu (deferasirox) tablets, a new oral formulation of Exjade (deferasirox) tablets for oral suspension, for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older, and chronic iron...

Posted today in Medical

Clues to 'Brain Fog' in Chronic Fatigue Patients Found in Spinal Fluid

People with chronic fatigue syndrome show a distinct pattern of immune system proteins in their spinal fluid -- a finding that could shed light on the "brain fog" that marks the condition, researchers say. The new study found that, compared with healthy people, those with chronic fatigue syndrome had lower levels of certain immune-system proteins called...

Posted today in Medical

Study Casts Doubt on Acetaminophen for Low Back Pain, Arthritis

Acetaminophen -- best known as Tylenol in the United States -- does not appear to help ease lower back pain and offers little relief for the most common form of arthritis, according to a new report. The review of data from 13 studies could challenge existing recommendations on pain relief, experts say. "These results support the reconsideration of recommendations...

Posted today in Medical

New Stroke Prevention Efforts May Be Paying Off

Fewer people are being treated in U.S. emergency rooms for strokes caused by blood clots in the brain, which experts read as a sign that current stroke prevention methods are working. The rate of emergency department visits for either a stroke or a mini-stroke (transient ischemic attack) -- a temporary blockage of blood flow to the brain -- decreased...

Posted today in Medical

Heart Groups Issue Updated Blood Pressure Guidelines

Three leading groups of heart experts have issued updated guidelines that set blood pressure goals for people with heart disease. Specifically, the guidelines reinforce a target blood pressure of less than 140/90 mm Hg for those at risk for heart attack and stroke. The guidelines also set a goal of 130/80 mm Hg for those with heart disease who have...

Posted today in Medical

Scientists Find More Evidence of Breast Milk's Goodness

A high-tech comparison of the breast milk of humans and their close primate relatives is revealing just how nutritious the human variety is. The research was led by Danielle Lemay, a nutritional biologist at the University of California, Davis' Genome Center. Her team used a new technique for identifying proteins found in breast milk. The researchers...

Read more news...

Recently added consumer and prescribing information: Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi, Evotaz, Prezcobix, Natpara, Prestalia

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.

Hide
(web4)